CT83全称为肿瘤-睾丸抗原83(英語:Cancer/testis antigen 83)是人类基因组X染色体CT83 编码的蛋白质[3],属于CT抗原之一,可在非小细胞肺癌英语Non-small-cell lung cancer(NSCLC)等癌症细胞上表达[4][5]

CT83
識別號
别名CT83;, CXorf61, KK-LC-1, KKLC1, cancer/testis antigen 83
外部IDOMIM300625 HomoloGene128483 GeneCardsCT83
基因位置(人类
X染色體
染色体X染色體[1]
X染色體
CT83的基因位置
CT83的基因位置
基因座Xq23起始116,461,686 bp[1]
终止116,462,976 bp[1]
直系同源
物種人類小鼠
Entrez
Ensembl
UniProt
mRNA​序列

NM_001017978

无数据

蛋白序列

NP_001017978

无数据

基因位置​(UCSC)Chr X: 116.46 – 116.46 Mb无数据
PubMed​查找[2]无数据
維基數據
檢視/編輯人類

参考文献 编辑

  1. ^ 1.0 1.1 1.2 GRCh38: Ensembl release 89: ENSG00000204019 - Ensembl, May 2017
  2. ^ Human PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine. 
  3. ^ Entrez Gene: Cancer/testis antigen 83. [2016-02-07]. (原始内容存档于2023-07-04). 
  4. ^ Baba, T; Shiota, H; Kuroda, K; Shigematsu, Y; Ichiki, Y; Uramoto, H; Hanagiri, T; Tanaka, F. Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2013-04, 43 (4): 759–64. PMID 22826471. doi:10.1093/ejcts/ezs426. 
  5. ^ Fukuyama, T; Hanagiri, T; Takenoyama, M; Ichiki, Y; Mizukami, M; So, T; Sugaya, M; So, T; Sugio, K; Yasumoto, K. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.. Cancer research. 2006-05-01, 66 (9): 4922–8. PMID 16651449. doi:10.1158/0008-5472.CAN-05-3840.